Researchers have identified a new mechanism driving the transformation of the Chagas disease parasite, Trypanosoma cruzi, as it adapts to infect humans and other mammals. The study, published in Nature Communications on August 21, 2026, reveals that modifications to transfer RNA (tRNA) molecules play a crucial role in this process.
The parasite undergoes significant changes in its protein expression during its life cycle, which are essential for infecting hosts. The research team, led by Dr. Juan Alfonzo at Brown University, discovered that a specific tRNA modification, known as mcm5s2U, is critical for the parasite to switch from its insect stage to the mammalian-infective stage. This modification affects the translation of proteins involved in the parasite's adaptation.
By manipulating the enzymes responsible for adding this modification, the scientists were able to prevent the parasite from transforming properly, reducing its ability to infect host cells. This finding opens new avenues for developing treatments that could block the parasite's life cycle and prevent Chagas disease, which affects about 6-7 million people worldwide, primarily in Latin America.
The study highlights the importance of tRNA modifications in regulating gene expression in pathogens, a relatively unexplored area. The researchers plan to further investigate whether similar mechanisms exist in other parasites, potentially leading to broader therapeutic applications.
